Title: Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013
Authors: Denis, Alain ×
Mergaert, Lut
Fostier, Christel
Cleemput, Irina
Simoens, Steven #
Issue Date: Jun-2010
Series Title: Journal of medical economics vol:13 issue:2 pages:295-301
Abstract: Objective: This article aims to calculate the impact of orphan drugs on the Belgian drug budget in 2008 and to forecast its impact over the following 5 years. Method: The 2008 budget impact was calculated by triangulating information derived from multiple Belgian data sources. The 2008-2013 budget impact analysis was based on three scenarios reflecting different levels of growth in the number of registered orphan drugs in the European Union, the number of drugs reimbursed in Belgium, and the average annual cost per patient per drug in Belgium. Results: The orphan drug budget impact amounted to euro66.2 million (or 5% of the Belgian hospital drug budget) in 2008. The impact would increase to euro130-204 million in 2013, depending on the scenario. Conclusions: This static analysis measured orphan drug costs only, assuming that other components of health expenditure do not change over time. The analysis showed that the budget impact of orphan drugs in Belgium is substantial and rising, thereby putting pressure on total drug expenditure. Policy options to address the rising budget impact include pricing linked to return on investment, risk-sharing arrangements and re-appraisal of orphan drug status if additional indications are approved.
ISSN: 1369-6998
VABB publication type: VABB-1
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Research Centre for Pharmaceutical Care and Pharmaco-economics (-)
Academic Centre for Nursing and Midwifery
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.